Laser Acupuncture (808 nm laser pen): Participants receive laser acupuncture using an 808 nm, 100 mW semiconductor laser pen applied at acupoints GV20, bilateral ST36, and bilateral PC6. Each acupoint is irradiated for 10 seconds, three times per week, for 12 weeks.
Sham Laser Acupuncture: Participants receive the same procedure as the laser acupuncture group, using an 808 nm semiconductor laser pen applied at acupoints GV20, bilateral ST36, and bilateral PC6. The device is identical in appearance and produces lights and beeping sounds; however, it delivers no energy output. Each acupoint is contacted for 10 seconds, three times per week, for 12 weeks.
Study summary
This study uses a laser acupuncture pen to stimulate specific acupoints, aiming to evaluate its effectiveness in improving behavioral and psychological symptoms of dementia (BPSD).
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Diagnosis of Dementia: Participants must have a clinical diagnosis of dementia, of any type or severity
* Consent: Written informed consent provided by the participant's family or legal representative.
Exclusion Criteria:
* Refusal to sign the informed consent form.
* Unable to cooperate with the intervention procedure despite repeated attempts.
* History of epilepsy.
* End-stage liver disease.
* End-stage renal disease requiring hemodialysis.
* Presence of brain tumor or history of major brain surgery.
* Acute cardiovascular or cerebrovascular events within the past 3 months (e.g., unstable angina, myocardial infarction, stroke).
* Use of a cardiac pacemaker.
* Currently receiving acupuncture or traditional Chinese medicine treatment.
* Presence of acute illness.
* Abnormal blood pressure or fever.
* Presence of malignant tumor.
* Pregnancy.
* Presence of unusual physical abnormalities or sensory nerve disorders.
Primary outcome measure(s)
Neuropsychiatric Inventory (NPI) total score — Baseline (before intervention), 1 week after first intervention, 1 month after first intervention, 2 months after first intervention, 3 months after first intervention, and 4 months after first intervention (also 1 month after the end of intervention) The Neuropsychiatric Inventory (NPI) assesses behavioral and psychological symptoms of dementia. The NPI total score ranges from 0 to 144, with higher scores indicating more severe symptoms (worse outcome).
Trial sites (2)
Facility
City
Region
Status
Taoyuan Veteran's Home
Taoyuan City
Bade District
China Medical University Hospital
Taichung
Taichung City
More China Medical University Hospital trials in Taiwan
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
